Oncology Market
Oncology Therapeutic Sector
In this section you will find information products, including market insight and company profiles.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
| Renal Cell Carcinoma Cancer Drug Futures | January 2012 | £1495 |
| Prostate Cancer Drug Futures | January 2012 | £1495 |
| Commercializing Angiogenesis Affecting Drugs in Cancer The Faster Route to Consider Your Options and Position of Others |
January 2012 | £2035 |
| Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 | January 2012 | £1265 |
| Gallbladder Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
January 2012 | £2525 |
| Analytical Tool - Apoptosis in Oncology | December 2011 | £2575 |
| Interacting with Oncology KOLs fulfilling unmet needs |
December 2011 | £735 |
| GV1001 (Pancreatic Cancer) Analysis and Forecasts to 2020 |
November 2011 | £1265 |
| Analytical Tool - Peptides in Oncology | November 2011 | £2575 |
| Analytical Tool - Antibodies and Peptides in Oncology | November 2011 | £4940 |
| Non-Small Cell Lung Cancer (NSCLC) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
November 2011 | £2215 |
| Talactoferrin Alfa (NSCLC) Analysis and Forecasts to 2020 |
October 2011 | £1265 |
| Retinoblastoma - Pipeline Review H2 2011 |
October 2011 | £315 |
| Chronic Myelocytic Leukemia (CML) - Pipeline Review H2 2011 |
October 2011 | £315 |
| Chronic Lymphocytic Leukemia (CLL) - Pipeline Review H2 2011 |
October 2011 | £315 |
| Lung Cancer Vaccines Pipeline, Strategies and Clinical |
October 2011 | £950 |
| Lung Cancer Vaccines and Therapeutic Antibodies | October 2011 | £1490 |
| Lung Cancer Therapeutic Antibodies Pipeline, Strategies and Clinical |
October 2011 | £750 |
| Paclitaxel (Ovarian Cancer) Analysis and Forecasts to 2020 |
September 2011 | £1265 |
| Glioblastoma Multiforme (GBM) Therapeutics Pipeline Assessment and Market Forecasts to 2018 |
September 2011 | £2215 |
| Acute Lymphocytic Leukemia (ALL) Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
September 2011 | £1265 |
| Oral Mucositis Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
August 2011 | £1265 |
| Oncology Pharmaceuticals Market in India 2011 |
August 2011 | £300 |
| Brivanib Analysis and Market Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| Linifanib Assessment and Market Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| Miripla Analysis and Market Forecasts from 2010 to 2020 |
July 2011 | £1265 |
| Muparfostat Analysis and Market Forecasts from 2017 to 2020 |
July 2011 | £1265 |
| Ramucirumab Analysis and Market Forecasts from 2014 to 2020 |
July 2011 | £1265 |
| Tarceva Analysis and Market Forecasts from 2013 to 2020 |
July 2011 | £1265 |
| ThermoDox Analysis and Market Forecasts from 2012 to 2020 |
July 2011 | £1265 |
